Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 801 | $6.446 | $5,163 | 235,255 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 1,582 | $6.528 | $10,327 | 236,056 (Direct) | View |
| 2024-05-17 Sale | 2025-02-27 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 15,093 | $14.84 | $223,965 | 237,638 (Direct) | View |
| 2023-11-03 Sale | 2023-11-14 8:59 pm | Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director | 78,388 | $0 | $0 | 0 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 7:28 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 3,557 | $19.06 | $67,796 | 94,546 (Direct) | View |
| 2022-03-30 Sale(A) | 2022-04-04 07:37 am | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 135,000 | $16.21 | $2,187,740 | 89,529 (Direct) | View |
| 2022-03-30 Sale | 2022-04-01 4:51 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 45,000 | $16.41 | $738,652 | 179,529 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2025-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 200,000 | $0 | 372,413 (Direct) | View |
Ownership | 2024-04-03 6:07 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 0 | $0 | 717,192 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 4:33 pm | N/A N/A | Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director | 25,641 | $0 | 78,388 (Direct) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 8,574 | $0 | 281,550 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 166,037 | $0 | 281,550 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 166,037 | $0 | 166,037 (Direct) | View |
| 2022-09-13 Option Award | 2022-09-15 9:06 pm | N/A N/A | Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director | 52,747 | $0 | 52,747 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-16 5:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 22,896 | $0 | 22,896 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 9:02 pm | N/A 2032-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 106,994 | $0 | 106,994 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 9:06 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David Chief Medical Officer | 213,101 | $1.21 | 262,838 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 9:06 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David Chief Medical Officer | 11,428 | $1.69 | 262,838 (Direct) | View |